Objectives of Biomarkers in Early Drug Development Biomarkers for Pharmacological Effects Biomarkers for (patho)physiological Principle Biomarkers for Therapeutic Principle Table 1 Number of Tests within Individual Domains Neuropsychological Domains Neuroleptics Selective Serotonin Re-uptake Inhibit
暂无分享,去创建一个
M. Ferrari | F. Zitman | D. Hilt | E. Bortey | A. Cohen | B. Slusher | S. D. de Visser | J. V. van Gerven | J. Vornov | H. Guchelaar | J. van der Post | M. D. de Kam | T. Limsakun | H. Middelkoop | E. Burak | A F Cohen | M. Woelfl Er | J. P. van der Post